ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $1,270,000 | -77.1% | 31,423 | -67.3% | 0.00% | -75.0% |
| Q2 2015 | $5,534,000 | +10.8% | 96,169 | +22.5% | 0.01% | 0.0% |
| Q1 2015 | $4,996,000 | -31.0% | 78,477 | -33.1% | 0.01% | -11.1% |
| Q4 2014 | $7,237,000 | +59.4% | 117,225 | +0.3% | 0.01% | +50.0% |
| Q3 2014 | $4,540,000 | +12.3% | 116,925 | -0.3% | 0.01% | +20.0% |
| Q2 2014 | $4,042,000 | -16.8% | 117,328 | +4.3% | 0.01% | -28.6% |
| Q1 2014 | $4,861,000 | +7.1% | 112,500 | -1.2% | 0.01% | 0.0% |
| Q4 2013 | $4,537,000 | +14.3% | 113,900 | +7.8% | 0.01% | +16.7% |
| Q3 2013 | $3,968,000 | +62.4% | 105,700 | +16.2% | 0.01% | +50.0% |
| Q2 2013 | $2,443,000 | – | 90,927 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 6,417,548 | $255,675,000 | 13.66% |
| HWG Holdings LP | 339,799 | $13,538,000 | 8.73% |
| DOWLING & YAHNKE LLC | 675,798 | $26,924,000 | 3.78% |
| GARRISON BRADFORD & ASSOCIATES INC | 99,300 | $3,956,000 | 3.74% |
| WILLIAM HARRIS INVESTORS INC | 283,834 | $11,308,000 | 3.35% |
| SECTORAL ASSET MANAGEMENT INC | 1,222,401 | $48,700,000 | 2.10% |
| AVALON CAPITAL MANAGEMENT | 49,999 | $1,992,000 | 1.68% |
| PINNACLE ASSOCIATES LTD | 2,016,369 | $80,332,000 | 1.57% |
| PERKINS CAPITAL MANAGEMENT INC | 48,515 | $1,933,000 | 1.30% |
| NCM Capital Advisers, Inc. | 31,100 | $1,239,000 | 1.28% |